NCT03080142View on ClinicalTrials.gov

TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Colorectal SurgeryTAP Blocks
Interventions
DRUG

Exparel

Patients will receive an injection of 30ml of volume to each abdominal side with a total of 60 ml for bilateral TAP blocks.

DRUG

Ropivacaine

Patients will receive 30ml of ropivicaine. Peripheral nerve catheters will be placed approximately 3-5cm into the TAP space and secured to the skin with tegaderm tape. Infusions will be ordered with CADD pumps and will be initiated at a rate of 8ml/hr of 0.2% ropivicaine on the inpatient floor.

Trial Locations (1)

95817

UC Davis Health, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT03080142 - TAP Block Catheters vs Liposomal Bupivacaine for Pain Control After Colorectal Surgery | Biotech Hunter | Biotech Hunter